The Obesity Drug Loophole. Plus, the Outlook for Homebuilder Stocks.
Barron's Streetwise
00:00
Intro
Exploring the recent downturn in US home builder stocks, attributing the decline to an uptick in home inventory rather than high mortgage rates or mixed economic signals, with detailed comparisons to the S&P 500 performance provided.
Transcript
Play full episode
